The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Validation of an artificial intelligence algorithm applied to a metabolic substrate analysis of urine for detection of urothelial cancer.
 
Nikola Kaludov
Employment - Abilis Life Sciences
Leadership - Abilis Life Sciences
Stock and Other Ownership Interests - Abilis Life Sciences
Research Funding - Abilis Life Sciences (Inst)
Patents, Royalties, Other Intellectual Property - Spark Therapeutics
 
Mohummad Minhaj Siddiqui
No Relationships to Disclose
 
Max Kates
No Relationships to Disclose
 
Hemantkumar Tripathi
No Relationships to Disclose
 
Amatul Nasir Salma
No Relationships to Disclose
 
Yair Lotan
Consulting or Advisory Role - AstraZeneca; Augmenix; BioCancell; MDxhealth; Merck; pacific edge; Photocure; Vessi Medical
Research Funding - Abbott Molecular (Inst); Augmenix; BioCancell (Inst); Cepheid; Cepheid (Inst); GenomeDx (Inst); MDxHealth (Inst); pacific edge; pacific edge (Inst); Photocure (Inst)
 
Gary D. Steinberg
Honoraria - AstraZeneca; Baxter; BioCancell; Bristol-Myers Squibb; CG Oncology; Epivax Oncology; Ferring; Fidia Farmaceutici S. p. A.; FKD Therapies; Heat Biologics; Janssen Oncology; MDxHealth; Merck; Natera; Photocure; Roche/Genentech; Sesen Bio; Taris Biomedical; Telesta Therapeutics; Urogen pharma
Consulting or Advisory Role - Boston Scientific; CG Oncology; Fidia Farmaceutici S. p. A.; Heat Biologics; MDxHealth; Merck; Natera; photocure; Roche/Genentech; Taris BioMedical